XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Revenues $ 2,510,000,000 $ 2,238,000,000 $ 7,066,000,000 $ 6,349,000,000
Expenses        
Selling, general and administrative 850,000,000 715,000,000 2,476,000,000 2,151,000,000
Research and development 146,000,000 153,000,000 453,000,000 452,000,000
Amortization of intangible assets 274,000,000 253,000,000 818,000,000 795,000,000
Goodwill impairments 0 402,000,000 0 402,000,000
Asset impairments 0 4,000,000 6,000,000 54,000,000
Restructuring, integration and separation costs 1,000,000 14,000,000 25,000,000 40,000,000
Other expense, net 225,000,000 60,000,000 245,000,000 0
Total expenses 2,192,000,000 2,224,000,000 6,078,000,000 5,748,000,000
Operating income 318,000,000 14,000,000 988,000,000 601,000,000
Interest income 7,000,000 6,000,000 24,000,000 19,000,000
Interest expense (346,000,000) (339,000,000) (1,051,000,000) (965,000,000)
Gain on extinguishment of debt 0 0 23,000,000 0
Foreign exchange and other 0 (7,000,000) (26,000,000) (38,000,000)
Loss before income taxes (21,000,000) (326,000,000) (42,000,000) (383,000,000)
Provision for income taxes (71,000,000) (56,000,000) (128,000,000) (181,000,000)
Net loss (92,000,000) (382,000,000) (170,000,000) (564,000,000)
Net loss attributable to noncontrolling interest 7,000,000 4,000,000 31,000,000 11,000,000
Net loss attributable to Bausch Health Companies Inc. $ (85,000,000) $ (378,000,000) $ (139,000,000) $ (553,000,000)
Basic loss per share attributable to Bausch Health Companies Inc. (in usd per share) $ (0.23) $ (1.03) $ (0.38) $ (1.52)
Diluted loss per share attributable to Bausch Health Companies Inc. (in usd per share) $ (0.23) $ (1.03) $ (0.38) $ (1.52)
Basic weighted-average common shares (in shares) 368.4 365.4 367.7 364.5
Diluted weighted-average common shares (in shares) 368.4 365.4 367.7 364.5
Product sales        
Revenues        
Revenues $ 2,482,000,000 $ 2,213,000,000 $ 6,990,000,000 $ 6,281,000,000
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 682,000,000 612,000,000 2,018,000,000 1,824,000,000
Other revenues        
Revenues        
Revenues 28,000,000 25,000,000 76,000,000 68,000,000
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 14,000,000 $ 11,000,000 $ 37,000,000 $ 30,000,000